Dear Dr. Roach: I am a 71-year-old woman who still works full-time as a teacher. I have osteoporosis and have had two bone scans. My latest scan showed a slight deterioration from the first two years ...

DEAR DR. ROACH: I am a 71-year-old woman who still works full-time as a teacher. I have osteoporosis and have had two bone scans. My latest scan showed a slight deterioration from the first two years ...

One annual infusion of zoledronic acid (Reclast) significantly reduces fracture risk in postmenopausal women with osteoporosis, according to results of a major trial. An international group of ...

Zoledronate (Zoledronic Acid) is a clinically proven treatment for osteoporosis that strengthens bones, reduces fracture risk, and improves long-term bone health. Delivered as a once-yearly ...

Researchers systematically consulted the Massachusetts General Hospital fracture liaison service for patients admitted to the orthopedics service with fragility fracture between February 2016 and ...

A treatment for osteoporosis delivered once a year is as effective as current monthly or weekly osteoporosis regimens at reducing the incidence of bone fractures, according to a new study led by a ...

Osteoporosis is a common skeletal disorder characterized by excessive bone loss, leading to increased fragility and an ...

One expert says a new osteoporosis drug may not be as exciting as many believe. May 8, 2007 — -- One might be convinced it's a glorious week for our aging bones. The Food and Drug Administration ...